Topic: How To Invest

Q: Pat, can I get your opinion on Crescita Therapeutics Inc. (CTX)? Based on its recent quarterly financial performance, I am interested in getting your insights. Also, what do you think of its recent cannabis deal? Thank you.

Article Excerpt

A: Crescita Therapeutics, $0.96, symbol CTX on Toronto (Shares outstanding: 21.0 million; Market cap: $20.1 million;, is a dermatology company with manufacturing capabilities, a portfolio of non-prescription skincare products for the treatment and care of skin conditions and diseases, and prescription drug products for the treatment of pain. Crescita specializes in drug delivery platforms that facilitate the active absorption of drugs into or through the skin. Nuvo Pharmaceuticals (symbol NRI on Toronto) spun off the company to its shareholders in March 2016. Supported by a sales force covering all of Canada, and focused on a business-to-business marketing approach, Crescita sells its non-prescription products primarily through spas, medispas and medical clinics. In addition, its brands and formulations are currently sold in the U.S. and Asia through international distributors and through a cross-border online channel. Crescita also provides contract development and manufacturing services to several local and North American clients. (Crescita operates out of a 50,000-square-foot manufacturing facility in Laval, Québec.) Specifically, it provides…

You are trying to access subscriber-only content.

To read this article, you may subscribe or sign in.
If you are already a subscriber, log in here.

If you wish to become a subscriber, click here. Or you may enjoy access to all our publications when you become a Member of Pat McKeough's Inner Circle Pro.